To reach their goal of transforming the Biopharma industry, AstraZeneca requested an architecture that could support streamlined data and analytics across the entire research and development (R&D) process.
Process: The OSTHUS blueprint
Assessed needs. After evaluating AstraZeneca’s Data and AI program for 90 days, we identified the following needs:
Streamlined data ingestion, processing, and advanced analytics
The ability to analyze internal and external data sets at enterprise scale across a variety of functions like omics, drug design, imaging, and more.
A cloud-based platform with an adaptable environment for a variety of data scientists
The ability to search across and move data between environments
The ability to process complex machine learning algorithms and predictive models
Support across the entire data lifecycle: gathering and preparing data, developing and testing ML and predictive models, and deploying into production
Created a blueprint. We developed an SDF architectural blueprint that leveraged existing infrastructures and outlined data processes, architecture requirements, and project scope.
Completed a solution alignment. During this process, we aligned the architecture with the environment to ensure an integrated science foundation.
Developed and implemented a detailed plan. We identified the role of linked data in the final architecture, designed a detailed project plan with resources and timelines for a cloud-first architecture, evaluated and selected the best-fit cloud suppliers for life science AI capabilities, and documented processes and requirements.
Solution: A hybrid cloud architecture
From April - July 2019, our interdisciplinary team of consultants, architects, data scientists, semantic experts, and cloud engineers designed and implemented the Science Data Foundation (SDF).
SDF is a transparent, robust architecture that seamlessly manages data from capture to consumption and maximizes the value of data as an asset.
Results: Decreased costs and accelerated time-to-market
The SDF architecture streamlined data movement and processing at enterprise scale, ensured master and reference data consistency, and provided added context from reliable sources of truth for maximum reuse. Our hybrid cloud architecture effectively conformed and contextualized data for downstream reporting and exploratory analysis.
By applying our data governance best practice guidelines, AstraZeneca noted improved data management and process flexibility across all scientific workflows. With both on-premise and cloud-based computation capabilities, AstraZeneca accelerated time-to-market and significantly reduced costs.
Michael Moskal II
Director of US Operations
Former Content Writer
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.